This inventor holds 1 USPTO granted patent. Top assignee: Mgi Tech Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Yue Yuan - Innovator in Single Cell Sequencing Technology
Introduction
Yue Yuan is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of biotechnology, particularly in the area of single cell sequencing. His innovative methods have the potential to advance research in genomics and personalized medicine.
Latest Patents
Yue Yuan holds a patent for a "Method for constructing single cell sequencing library and use thereof." This patent outlines a comprehensive approach to constructing single cell sequencing libraries, which includes lysing a single cell to obtain a lysate, separating the nucleus and cytoplasm, and constructing both chromatin DNA and transcriptome libraries. This method enhances the ability to analyze individual cells, providing valuable insights into cellular functions and behaviors.
Career Highlights
Yue Yuan is associated with MGI Tech Co., Ltd., a company known for its cutting-edge technologies in genomics and sequencing. His work at MGI Tech has positioned him as a key player in the development of innovative solutions for genomic research.
Collaborations
Yue Yuan collaborates with notable colleagues, including Longqi Liu and Chuanyu Liu. These partnerships foster a collaborative environment that enhances the development of new technologies and methodologies in the field.
Conclusion
Yue Yuan's contributions to single cell sequencing technology exemplify the impact of innovative thinking in biotechnology. His patent and work at MGI Tech Co., Ltd. highlight the importance of advancing scientific research through novel methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile